Illustration depicting RSV prevention injection in a newborn, shielding from virus and reducing future asthma risk, with healthy child growth.
Àwòrán tí AI ṣe

RSV prevention in newborns could cut childhood asthma risk, study suggests

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

Belgian researchers working with Danish partners report that respiratory syncytial virus (RSV) infections in early infancy are linked to a higher risk of childhood asthma, especially in children with a genetic tendency to allergies. In experimental models, protecting newborns from RSV prevented the immune changes associated with later asthma. The findings, published in Science Immunology, highlight potential long-term benefits of emerging RSV prevention tools.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ